Evidence map›Paper›PMID 36330100›Full record

ArticleFrontiers in pharmacology2022

Nano-drug delivery system for pancreatic cancer: A visualization and bibliometric analysis.

Jie-Feng Zhao, Fei-Long Zou, Jin-Feng Zhu, Chao Huang, Fan-Qin Bu, Zheng-Ming Zhu, Rong-Fa Yuan

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jie-Feng ZhaoDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Fei-Long ZouDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Jin-Feng ZhuDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Chao HuangDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Fan-Qin BuDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Zheng-Ming ZhuDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Rong-Fa YuanDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bibliometric analysisCiteSpacenano-drug delivery systempancreatic cancerR-bibliometrixVOSviewer

Identifiers

PMID36330100
PMCPMC9622975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.